APA (7th ed.) Citation

Y, L., A, W., Y, C., S, M., S, B., S, M., . . . C, P. (2026). EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway. Haematologica. https://doi.org/10.3324/haematol.2025.288024

Chicago Style (17th ed.) Citation

Y, Li, et al. "EZH2 Inhibition Overcomes Immunomodulatory Drug Resistance in Multiple Myeloma via a Cereblon-dependent Pathway." Haematologica 2026. https://doi.org/10.3324/haematol.2025.288024.

MLA (9th ed.) Citation

Y, Li, et al. "EZH2 Inhibition Overcomes Immunomodulatory Drug Resistance in Multiple Myeloma via a Cereblon-dependent Pathway." Haematologica, 2026, https://doi.org/10.3324/haematol.2025.288024.